respiratory infections

The therapeutic may prevent overactive immune systems from causing severe COVID-19-related illness

2023 fall–winter is the first season when vaccines for all three major respiratory viruses are available

According to the CDC, RSV is the leading cause of infant hospitalization in the US and warrants immediate preventive action

Pediatric hospitalizations for RSV infection in 2021–2022 equaled nearly half of all such hospitalizations in the past five years

RSV vaccination may prevent severe respiratory illnesses and hospitalization in seniors at risk

Research-backed, low-cost testing supporting allergy diagnosis is now easily available to more people in more communities

A single dose of Arexvy reduced the risk of developing severe RSV-associated respiratory disease by 94.1 percent

Updates on respiratory syncytial virus (RSV), including diagnostic tools and treatment options

New single molecular diagnostic test can detect and differentiate multiple respiratory infectious diseases

This document updates the previous guide with the latest recommendations regarding new tools for diagnosis